Discontinuation report APO-LAMIVUDINE

Last updated on 2019-07-13 History
Report ID 60560
Drug Identification Number 02369060
Brand name APO-LAMIVUDINE
Common or Proper name LAMIVUDINE
Company Name APOTEX INC
Active Ingredient(s) LAMIVUDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-07-04
Actual discontinuation date 2019-07-12
Remaining supply date 2019-07-12
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-07-13 English Compare
v4 2019-07-12 French Compare
v3 2019-07-12 English Compare
v2 2018-09-07 French Compare
v1 2018-09-07 English Compare